Company / Total Assets
Lexaria Bioscience Corp. Total Assets History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$4.2M
FY2025
5-year range
$3.1M / $13.3M
FY2021-FY2025
Trend
-52.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $566,638 in FY2016 to $13M in FY2021.
Based on SEC 10-K filings.
$4M in FY2025 with a 10-year CAGR of +19.4%.
Improved from $3M to $4M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -18.9%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- +19.4%
Key checks
Key Insights
- 5-year CAGR of +8.1%, indicating consistent growth.
- In FY2025, total assets decreased 52.9% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.2M | -52.9% |
| FY2024 | $8.9M | +187.5% |
| FY2023 | $3.1M | -60.6% |
| FY2022 | $7.8M | -41.0% |
| FY2021 | $13.3M | +369.1% |
| FY2020 | $2.8M | +5.7% |
| FY2019 | $2.7M | -6.5% |
| FY2017 | $2.9M | +404.8% |
| FY2016 | $566.6K | -20.4% |
| FY2015 | $711.7K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026